| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |